Skip to main content

Result releasedAnnolyse analysis published

Third Age Health lifts PBT 37.7% while cash conversion slips to 50.5%

Revenue rose 20.8% and PBT grew 37.7%, but operating cash conversion fell to 50.5% of EBITDA from 55.1% as receivables grew faster than sales.

TAH revenue trajectory

Revenue context before the current result.

Loading chart...
FY26 was $22.5m, versus $11.5m in FY23.

TAH EBITDA margin

EBITDA margin across covered periods.

Loading chart...
FY26 was 25.6%, versus 13.6% in FY23.

TAH operating cash flow

Operating cash flow across covered periods.

Loading chart...
FY26 was $4m, versus $1.1m in FY23.

TAH NPAT trajectory

Statutory profit after tax across covered periods.

Loading chart...
FY26 was $2.8m, versus $0.4m in FY23.

Market context

Valuation

These ratios pair a market close from around the result date with verified filing data. An unavailable metric means the required inputs were missing or unsuitable for comparison.

Prices as at close, 29 October 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$43.1m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

Not available

i

Not available for this company right now.

EPS

Not available

i

Not available for this company right now.

PEG

Not available

i

Not available for this company right now.

EV/EBITDA

Not available

i

Not available for this company right now.

P/FCF

Not available

i

Not available for this company right now.

P/B

6.5x

i

Market value compared with latest reported equity.

Income and investment-company measures

Yield and investment-company valuation where supported.

Dividend yield

3.7%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Release date
30 October 2026
Published
30 October 2026

Key metrics

Numbers worth scanning first

HY27 vs HY26

Revenue

$12.9m

Caveat: metric quality flags apply; use this value with basis context.

EBITDA

$3.7m

Caveat: metric quality flags apply; use this value with basis context.

Net profit after tax

$1.8m

Caveat: metric quality flags apply; use this value with basis context.

Net cash inflow from operating activities

$1.9m

Caveat: metric quality flags apply; use this value with basis context.

Final dividend per share

4.0c

Caveat: metric quality flags apply; use this value with basis context.

Profit before tax

$3m

Caveat: metric quality flags apply; use this value with basis context.

Cash and cash equivalents

$3m

+90.0% ↑ vs $1.6m

Total assets

$13.7m

Caveat: metric quality flags apply; use this value with basis context.

Analysis ofTAH HY27Result releasedAnnolyse analysis published

What changed

Third Age Health grew revenue 20.8% to $12.9 million and EBITDA 34.1% to $3.7 million, with profit before tax up 37.7% to $2.954 million and net profit after tax up 30.1% to $1.841 million

The headline growth is strong, but operating cash flow of $1.87 million (+22.9%) did not keep pace, so cash conversion fell to 50.5% of EBITDA from 55.1% in the prior comparable period.

Within the business, the aged medical care services segment contributed the larger result at $2.696 million, against $0.258 million from general practice medical services, indicating a mix increasingly weighted toward the former. Receivable days rose to 25.5 from 22.8.

On the balance sheet, cash climbed to $3.0 million from $1.579 million and gross borrowings fell 7.9% to $1.061 million, while equity rose 37.7% to $6.632 million, leaving the group in a stronger net cash position than a year earlier.

What matters

Cash conversion falling to 50.5% from 55.1% matters because it means a growing share of reported earnings is not yet showing up as collected cash, even though profit growth looks robust on paper; this is the clearest quality caveat in an otherwise strong result

Receivable days rising to 25.5 from 22.8 is consistent with that pattern, though the data available does not establish whether this is a timing issue or a structural shift in collection terms.

The segment split shows general practice medical services contributing a markedly smaller result ($0.258 million) than aged medical care services ($2.696 million), so the earnings base is increasingly concentrated in one segment; investors should watch whether that concentration changes the group's margin profile over time.

The gap between PBT growth (37.7%) and NPAT growth (30.1%) is better explained by the bridge from group profit ($2.104 million) to owners' NPAT ($1.841 million) after a $0.263 million allocation to non-controlling interests than by tax, since the effective tax rate was broadly stable at 28.8% versus 29.1% a year earlier. This means the PBT-to-NPAT gap reflects ownership structure rather than a change in the group's tax position.

Expectations

No stated full-year target or formal guidance was disclosed for FY27, so this result cannot be benchmarked against a numeric commitment; it can only be read as a standalone half

The prior full year's reported half-year split showed the first half contributing 47.4% of full-year revenue, 48.0% of full-year EBITDA and 50.1% of full-year NPAT, but this is a reported-basis split from a different period and should not be used to infer this period's second-half trading momentum.

With no forward-work disclosure or dividend guidance for cents per share next year, the release supports a read on first-half performance but not a read on what management expects for the balance of FY27.

Quality of result

Part of the result looks durable: revenue and EBITDA growth were broad enough to lift PBT by 37.7%, and capex intensity was minimal at 0.3% of revenue, keeping free cash flow close to net profit at 99.2% of NPAT, albeit down from 105.2% in the prior comparable period

The softer cash-conversion figure and the rise in receivable days nonetheless signal that a portion of the earnings growth has not yet converted into cash in hand, which tempers how far the profit growth alone can be read as a cash-generation improvement.

The period-end working-capital balance also increased, which analytical_calculations characterises as a partial balance-proxy rather than a confirmed in-period cash-flow movement, so it should not be treated as evidence that earnings did or did not convert to cash; that judgement rests on the operating cash flow and conversion figures cited above.

Unresolved

Open questions

Why did operating cash conversion fall to 50.5% of EBITDA from 55.1%, and does management expect this to normalise in the second half?
What is driving the increase in receivable days to 25.5 from 22.8, and is it collection timing or a change in customer terms?
How does management view the widening gap in result contribution between aged medical care services ($2.696 million) and general practice medical services ($0.258 million) for future margin mix?
Will the stronger net cash position and lower gross borrowings support any change to dividend policy, given no full-year dividend guidance has been disclosed?

This briefing cannot assess the underlying drivers behind any corporate activity referenced in the period, nor benchmark the result against management guidance, since no verified transaction details or forward targets were supplied.

Ask about TAH HY27

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Third Age Health Services's HY27 result.

Why did operating cash conversion fall to 50.5% of EBITDA from 55.1%, and does management expect this to normalise in the second half?Why does "Cash conversion falling to 50.5% from 55.1% matters because it means a growing share of reported earnings is not yet showing up as collected cash, even though profit growth looks robust on paper; this is the clearest quality caveat in an otherwise strong result" matter?How strong was the cash and earnings quality in HY27?What should I watch next for TAH after HY27?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

TAH 1H FY27 Unaudited company filing

HY27 / results announcement

TAH 1H FY27 Unaudited Interim Financial Statements

HY27 / financial report

Prior comparable period

TAH 1H FY26 Unaudited company filing

HY26 / results announcement

TAH 1H FY26 Unaudited company filing

HY26 / results release

TAH 1H FY26 Unaudited Interim Financial Statements

HY26 / financial report

Full-year context

FY26 Third Age Health Annual Report

FY26 / financial report

TAH NZX Release of Annual Report 2026

FY26 / results announcement

Release context

Revised date for Q1 FY27 Trading Update

FY26 / commentary

Get notified when TAH publishes next

Get the next Third Age Health Services briefing and related NZX reporting-season updates by email.